o 129 has been researched along with triamterene in 1 studies
| Studies (o 129) | Trials (o 129) | Recent Studies (post-2010) (o 129) | Studies (triamterene) | Trials (triamterene) | Recent Studies (post-2010) (triamterene) |
|---|---|---|---|---|---|
| 30 | 0 | 2 | 1,212 | 181 | 86 |
| Protein | Taxonomy | o 129 (IC50) | triamterene (IC50) |
|---|---|---|---|
| Janus kinase 2 (a protein tyrosine kinase) | Homo sapiens (human) | 4.613 | |
| Cathepsin G | Homo sapiens (human) | 7.413 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
| Caspase-1 | Homo sapiens (human) | 3.663 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gibson, CL; Huggan, JK; Hunter, WN; Iulek, J; Lee, JH; Martini, VP; Smith, TK; Suckling, CJ; Tulloch, LB | 1 |
1 other study(ies) available for o 129 and triamterene
| Article | Year |
|---|---|
Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
Topics: Catalytic Domain; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Leishmania major; Leishmaniasis; Models, Molecular; Molecular Structure; Oxidoreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Trypanosoma brucei brucei; Trypanosomiasis, African | 2010 |